A metabolic-radioimmune signature predicts therapy response and immune reprogramming in non-small cell lung cancer
{{output}}
Objective: This study systematically investigates radiotherapy-induced metabolic remodeling across the TME, encompassing tumor cells, immune cells, and tumor-draining lymph nodes (TDLNs), and establishes a prognostic signature ba... ...
